CRS: Whitman-Walker
Position: Pharmacist of Record
1077BF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
Using existing data from A5274 and data obtained from retrospectively testing available biospecimens, we propose the following...
A5361s is a prospective study to determine the effects of pitavastatin on physical function. The study will enroll participants...
IMPAACT P1026s, the predecessor of this study, was first approved in 2003. P1026s enrolled over 1000 pregnant/postpartum women,...
A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...
